Press Archive
- Mark D. Mayle, MD - 2022 Secretariat Award Recipients
- Dr. Larry Schwab recognized with 2020 International Blindness Prevention Award
- Wow Moment with Joseph A. LoCasio | Bio-Tissue | #WowWednesdays
- WVU Today | Moore, Oppe named recipients of Heebink award for Distinguished Service
- Cornea Transplant Restores Young Boy’s Sight After Fishing Accident
- Keep your eyes healthy and safe in the workplace
- Glaucoma Awareness Month
- Ophthalmologists Say 90 Percent of Work-Related Eye Injuries Can be Avoided by Wearing Eye Protection
- Five Tips to Avoid Toy-Related Eye Injuries
- Reputable Ophthalmologist Vk Raju, MD, FRCS, FACS, will be Noted in The Leading Physicians of the World
Find an Eye MD near you!
- Details
Embattled drugmaker Valeant Pharmaceuticals has struck a deal with Walgreens to distribute some of its drugs at a 10% discount.
- Details
Mundipharma and Purdue Pharma Canada have acquired marketing rights to Merck’s glaucoma portfolio outside of the United States.
Read more: Merck continues to divest its ophthalmology products
- Details
Cellceutix Corporation announced that the U.S. FDA granted rare pediatric disease designation to kevetrin for the treatment of retinoblastoma.
Read more: Retinoblastoma drug granted rare pediatric disease designation
- Details
Communicating with patients using cap color exclusively could lead to confusion and harm, especially when treating patients with more advanced disease.
- Details
A retrospective study found that a commonly prescribed drug for Parkinson’s, L-DOPA, may delay or prevent AMD.
- Details
This study adds to the growing body of literature that suggests natamycin may be more effective for treating fungal keratitis than voriconazole.